Boston Scientific reaches $2 billion accelerated share repurchase agreement

Global Marketwire May 19｜Medical device manufacturer Boston Scientific announced that it has signed an Accelerated Share Repurchase Agreement (ASR) with a certain exchange for $2 billion in stock, as part of the previously announced $5 billion share repurchase authorization plan. The final settlement is expected to be completed by June 30, 2026, and it is expected that this ASR transaction will increase Boston Scientific’s recently announced adjusted earnings per share guidance for fiscal year 2026 by $0.02.